Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Clinical trial NCT07018063 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07018063
Sponsor: zhoujing
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric (Cardia, Body) Cancer Stomach Adenocarcinoma Locally Advanced

Start date: 2025-10-01
Primary completion: 2027-12-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.